Next Article in Journal
Ad Hoc Afatinib in an Eldery Lung Cancer Patient with EGFR Exon 19 Deletion L747-A750>P
Previous Article in Journal
Pulmonary Toxicities of Immune Check Point Inhibitors in the Management of Cancer: Mini Review
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Should a Prescription Database Be Used to Search Uncontrolled Severe Asthmatics?

by
Bruno Sposato
1,2,*,
Elisa Petrucci
3,
Fabio Lena
3,
Leonardo Gianluca Lacerenza
3,
Michele Bindi
3,
Andrea Montagnani
4,
Antonio Perrella
1 and
Marco Scalese
5
1
Pneumology Department, Azienda USL Toscana Sud-Est, “Misericordia” Hospital, Grosseto, Italy
2
Experimental Medicine and Systems, “PhD program” Department of Systems Medicine University of Rome “Tor Vergata”, Rome, Italy
3
Department of Pharmaceutical Medicine, Azienda USL Toscana Sud-Est, “Misericordia” Hospital, Grosseto, Italy
4
Department of Internal Medicine and Specialties, USL Tuscany South-East, Tuscany, Italy
5
Institute of Clinical Physiology, National Research Council, Pisa, Italy
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2022, 90(3), 230-233; https://doi.org/10.5603/ARM.a2022.0019
Submission received: 9 August 2021 / Revised: 14 December 2021 / Accepted: 14 December 2021 / Published: 31 January 2022

Abstract

Introduction: Many uncontrolled severe asthmatics are not on biologic therapy. We hypothesized that using a prescription database could help us identify them. Material and Methods: 3309 patients who received at least one Montelukast prescription in 2019 were extracted from our prescription database. Number of packages/year, types and dosages of ICS, LABA, ICS/LABA, LAMA and monoclonal antibodies were considered for each patient. In our analysis, for subjects that took > 7 packages of ICS/LABA + LTRA +/– LAMA (high adherent) the number of oral corticosteroids (OC) packets prescribed for each of them was also looked upon. Results: Patients that took ICS/LABA or ICS/LABA + LAMA continuously with high ICS doses were 188 (25.6%) and 117 (39.3%) respectively (total: 305 — 29.5%). Among them, 58 (30.9%) and 53 (45.3%) (total: 111 — 36.4%) were prescribed more than 2 OC packages. Whereas, 21 (11.2%) and 24 (20.5%) patients (total: 45 — 14.75%) received at least 4 OC package prescriptions. Conclusion: Approximately 36% of patients in continuous step-4/5 of GINA Guideliness treatment may have severe uncontrolled asthma (overusing OC) which needed biologic treatment. In our opinion, a prescription archiving database may be a tool that can help us identify such uncontrolled asthma patients.
Keywords: asthma; severe; prescription; electronic database; biologic; treatment asthma; severe; prescription; electronic database; biologic; treatment

Share and Cite

MDPI and ACS Style

Sposato, B.; Petrucci, E.; Lena, F.; Lacerenza, L.G.; Bindi, M.; Montagnani, A.; Perrella, A.; Scalese, M. Should a Prescription Database Be Used to Search Uncontrolled Severe Asthmatics? Adv. Respir. Med. 2022, 90, 230-233. https://doi.org/10.5603/ARM.a2022.0019

AMA Style

Sposato B, Petrucci E, Lena F, Lacerenza LG, Bindi M, Montagnani A, Perrella A, Scalese M. Should a Prescription Database Be Used to Search Uncontrolled Severe Asthmatics? Advances in Respiratory Medicine. 2022; 90(3):230-233. https://doi.org/10.5603/ARM.a2022.0019

Chicago/Turabian Style

Sposato, Bruno, Elisa Petrucci, Fabio Lena, Leonardo Gianluca Lacerenza, Michele Bindi, Andrea Montagnani, Antonio Perrella, and Marco Scalese. 2022. "Should a Prescription Database Be Used to Search Uncontrolled Severe Asthmatics?" Advances in Respiratory Medicine 90, no. 3: 230-233. https://doi.org/10.5603/ARM.a2022.0019

Article Metrics

Back to TopTop